Evidence map›Paper›PMID 42774155›Full record

ArticleFrontiers in oncology2026

Case Report: Postpartum diagnosis and microsurgical management of a cervicothoracic intramedullary spinal ependymoma clinically manifesting during the third trimester of pregnancy.

Talgat T Kerimbayev, Daryn Borangaliyev, Azamat Abenov, Daniyar K Zhamoldin, Galymzhan Kadirbekov, Zhandos Tuigynov, Yergen Kenzhegulov, Viktor G Aleinikov, Berik Zhetpisbayev, Yermek Urunbayev and 6 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Talgat T KerimbayevDepartment of Spinal Neurosurgery and Peripheral Nervous System Pathology, Joint Stock Company (JSC) "National Centre for Neurosurgery", Astana, Kazakhstan.
Daryn BorangaliyevDepartment of Spinal Neurosurgery and Peripheral Nervous System Pathology, Joint Stock Company (JSC) "National Centre for Neurosurgery", Astana, Kazakhstan.
Azamat AbenovDepartment of Spinal Neurosurgery and Peripheral Nervous System Pathology, Joint Stock Company (JSC) "National Centre for Neurosurgery", Astana, Kazakhstan.
Daniyar K ZhamoldinDepartment of Minimally Invasive Neurosurgery, Joint Stock Company Joint Stock Company (JSC) "National Centre for Neurosurgery", Astana, Kazakhstan.
Galymzhan KadirbekovDepartment of Spinal Neurosurgery and Peripheral Nervous System Pathology, Joint Stock Company (JSC) "National Centre for Neurosurgery", Astana, Kazakhstan.
Zhandos TuigynovDepartment of Spinal Neurosurgery and Peripheral Nervous System Pathology, Joint Stock Company (JSC) "National Centre for Neurosurgery", Astana, Kazakhstan.
Yergen KenzhegulovDepartment of Minimally Invasive Neurosurgery, Joint Stock Company Joint Stock Company (JSC) "National Centre for Neurosurgery", Astana, Kazakhstan.
Viktor G AleinikovDepartment of Minimally Invasive Neurosurgery, Joint Stock Company Joint Stock Company (JSC) "National Centre for Neurosurgery", Astana, Kazakhstan.
Berik ZhetpisbayevJoint Stock Company (JSC) "National Centre for Neurosurgery", Astana, Kazakhstan.
Yermek UrunbayevDepartment of Minimally Invasive Neurosurgery, Joint Stock Company Joint Stock Company (JSC) "National Centre for Neurosurgery", Astana, Kazakhstan.
Nurzhan AbishevDepartment of Spinal Neurosurgery and Peripheral Nervous System Pathology, Joint Stock Company (JSC) "National Centre for Neurosurgery", Astana, Kazakhstan.
Meirzhan OshayevDepartment of Spinal Neurosurgery and Peripheral Nervous System Pathology, Joint Stock Company (JSC) "National Centre for Neurosurgery", Astana, Kazakhstan.
Aisa Z NurperisovJoint Stock Company (JSC) "National Centre for Neurosurgery", Astana, Kazakhstan.
Zhanibek BaiturlinJoint Stock Company (JSC) "National Centre for Neurosurgery", Astana, Kazakhstan.
Makar SolodovnikovJoint Stock Company (JSC) "National Centre for Neurosurgery", Astana, Kazakhstan.
Serik K AkshulakovJoint Stock Company (JSC) "National Centre for Neurosurgery", Astana, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Intramedullary spinal cord ependymomas are the most common intramedullary tumours in adults. However, clinical manifestation during pregnancy is exceptionally rare, and diagnosis may be delayed because pain, sensory disturbances, and muscle weakness are often mistakenly attributed to the common musculoskeletal changes associated with pregnancy. Case description: A 29-year-old multiparous woman developed progressive back pain, numbness, and weakness in both lower extremities at 30 weeks of gestation. She was initially managed conservatively. Following an uncomplicated spontaneous delivery at 38 weeks of gestation, her neurological condition deteriorated rapidly, with the development of severe spastic paraparesis, sensory impairment below the T1 level, urinary retention, and constipation. Magnetic resonance imaging revealed a centrally located contrast-enhancing intramedullary tumour extending from C7 to T5, accompanied by fusiform expansion of the spinal cord. On postpartum day 38, the patient underwent C7-T5 laminectomy, midline myelotomy, and microsurgical gross total resection of the tumour under multimodal intraoperative neurophysiological monitoring. Despite intraoperative deterioration of left-sided motor responses, no postoperative worsening of the neurological deficit or other surgery-related complications were observed. Following multidisciplinary tumour board review, adjuvant proton beam therapy was delivered to the tumour bed at a total dose of 54 Gy. Сontrast follow-up MRI performed at 6 months showed no convincing evidence of disease progression; Initial histopathological examination classified the tumour as an ependymoma, NOS, CNS WHO grade 3. Molecular testing revealed no mutations in the IDH1 or IDH2 genes; a heterozygous deletion of the MYB gene was additionally identified. The tumour specimen was referred for further specialist neuropathological review. At 6-month follow-up, lower-extremity muscle strength had improved from Medical Research Council grade 2/5 to 3-4/5, functional status had improved from grade IV to grade III on the modified McCormick scale, and partial recovery of bladder function was observed. No clinical or radiological evidence of disease progression was identified. Conclusion: The development of progressive motor deficit, a defined sensory level, pyramidal signs, or sphincter dysfunction during pregnancy or the postpartum period warrants urgent neurological assessment and MRI of the spine and spinal cord.

Indexed as

intramedullary spinal cord tumourmicrosurgical resectionpostpartum periodpregnancyspinal ependymoma

Identifiers

PMID42774155
PMCPMC13593514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.